Anne Wojcicki has resigned as CEO of 23andMe, with the announcement coming alongside the company's bankruptcy protection filing. Having co-founded the genetic testing firm in 2006, Wojcicki aimed to democratize access to genetic insights. Despite its innovative approach, the company faced numerous challenges, including privacy concerns, declining demand, and management disagreements. Notably linked to tech moguls through her family ties, Wojcicki's leadership took 23andMe public in 2021. The company's high initial testing prices were eventually lowered to reach broader audiences, reflecting the evolution of the genetic testing market.
Anne Wojcicki has stepped down as CEO of 23andMe, coinciding with the company's bankruptcy filing.
Wojcicki's resignation follows a tumultuous period for 23andMe, marked by privacy issues, layoffs, and declining demand.
The company, co-founded in 2006, aimed to help individuals understand their genomes through affordable genetic testing.
23andMe's initial testing kit was priced at $999 but later offered more accessible options at $99 and $199.
Collection
[
|
...
]